CN100444850C - Chinese traditional medicine for treating skin diseases - Google Patents
Chinese traditional medicine for treating skin diseases Download PDFInfo
- Publication number
- CN100444850C CN100444850C CNB2003101077708A CN200310107770A CN100444850C CN 100444850 C CN100444850 C CN 100444850C CN B2003101077708 A CNB2003101077708 A CN B2003101077708A CN 200310107770 A CN200310107770 A CN 200310107770A CN 100444850 C CN100444850 C CN 100444850C
- Authority
- CN
- China
- Prior art keywords
- shares
- radix
- present
- skin diseases
- chinese traditional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a traditional Chinese drug for treating dermatosis, which is prepared from 15 to 20 shares of angelica, 15 to 20 shares of safflower, 15 to 20 shares of red sage root, 15 to 20 shares of myrrh, 15 to 20 shares of astragalus and 15 to 20 shares of bupleurum root. When used for treating various kinds of dermatosis such as psoriasis, ichthyosis, eczema, seborrheic dermatitis, etc., the product of the present invention has favorable effect, an effective rate of 98% and no toxic or side effect.
Description
(1) technical field
What the present invention relates to is a kind of raw-material medical configuration product that contain.Specifically a kind ofly be used for the treatment of dermopathic Chinese medicine preparation.
(2) background technology
It is a lot of to be used for the treatment of dermopathic medicines such as psoriasis, ichthyosis, eczema, seborrheic dermatitis at present.Contain the hormones composition mostly in its Chinese medicine and western medicine ointment.Life-time service can have a negative impact to human body.Also have some Chinese medicine preparations to be used to treat dermatosis, but curative effect is unsatisfactory.
(3) summary of the invention
The object of the present invention is to provide a kind of having no side effect, the dermopathic Chinese medicine of the treatment that therapeutic effect is good.
The object of the present invention is achieved like this: it is made up of Radix Angelicae Sinensis 15-20 part, Flos Carthami 15-20 part, Radix Salviae Miltiorrhizae 15-20 part, Myrrha 15-20 part, Radix Astragali 15-20 part, Radix Bupleuri 15-20 part.After various raw material pulverizing are made powder, record into capsule or add the adjuvant of making pill and make pill and all can.
The dry root that ought be classified as umbelliferae angelica in the product of the present invention, contain volatile oil, main aroma ingredients is the butenoic acid lactone and faces hydroxy benzenes pentanone etc., and it also contains sucrose and Palmic acid, cupreol and cetylate, nicotinic acid, vitamin E, vitamin B in addition
12Deng.Radix Angelicae Sinensis acrid-sweet flavor warm in nature, have enrich blood, invigorate blood circulation, effect such as antibacterial; Flos Carthami is the dry tubular flower of feverfew Flos Carthami.Contain carthamin, Flos Carthami quinone glycoside, neocarthamin.Flos Carthami mildly bitter flavor suffering warm in nature.Effect with promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing; Radix Salviae Miltiorrhizae is the dry root of labiate Radix Salviae Miltiorrhizae.The derivant of the fat-soluble multiple tanshinone of oil-containing and water miscible original pair tea phenol aldehyde and catechol.Radix Salviae Miltiorrhizae cold nature bitter in the mouth.Have activating blood and removing stasis, menstruction regulating and pain relieving, calming heart and tranquilizing mind promotion tissue repair, bacteriostatic effect; Myrrha is the olive subject plant myrrh and belongs to the oleo-gum-resin that other plant backbone skin zone oozes out together.Contain resin, volatile oil, natural gum and amaroid etc.Myrrha nature and flavor hardship.Effect with promoting blood circulation and stopping pain, detumescence and promoting granulation; The Radix Astragali is the leguminous plant Radix Astragali or the dry root that covers the Radix Astragali.Contain that choline is sweet, dish alkali polysaccharide, pectin starch, aminoacid bitter principle and micro-folic acid etc.Radix Astragali slightly warm in nature bitter in the mouth has effects such as invigorating QI to consolidate the body surface resistance, expelling pus and toxin by strengthening QI, granulation promoting diuresis; Radix Bupleuri is samphire Radix Bupeuri Scorzonerfolii., Radix Bupleuri and dry root or the herb that belongs to other plant together.Contain volatile oil Saponin, fatty oil, contain bupleurumol, various plants sterol etc. in addition.Radix Bupleuri bitter in the mouth cold nature has in the harmony in the exterior of separating, brings down a fever, effect such as the soothing the liver accent in Kaiyang is strongly fragrant.
The present invention between each composition coordinates these drug regimens mutually, can receive effects such as good activating blood circulation to dissipate blood stasis, promoting the circulation of QI to relieve pain, QI invigorating and body resistance strengthening, detumescence and promoting granulation, expelling pus and toxin by strengthening QI.The experiment proved that product of the present invention is used for the treatment of various skin diseases such as psoriasis, ichthyosis, eczema, seborrheic dermatitis and has good effect, effective percentage can reach 98%.Product of the present invention is pure Chinese medicinal preparation, and is without any side effects.
(4) specific embodiment
For example the present invention is done in more detail below and describes:
Ratio according to Radix Angelicae Sinensis 15-20 part, Flos Carthami 15-20 part, Radix Salviae Miltiorrhizae 15-20 part, Myrrha 15-20 part, Radix Astragali 15-20 part, Radix Bupleuri 15-20 part is got raw material ready.After various raw material pulverizing are made powder, record into capsule or add the adjuvant of making pill and make pill.
Ratio according to 15 parts of Radix Angelicae Sinensis, 15 parts on Flos Carthami, 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of Myrrhas, 15 parts of the Radixs Astragali, 15 parts of Radix Bupleuri is got raw material ready.After various raw material pulverizing are made powder, record into capsule or add the adjuvant of making pill and make pill.
Claims (1)
1, the dermopathic Chinese medicine of a kind of treatment is characterized in that: it is made up of Radix Angelicae Sinensis 15-20 part, Flos Carthami 15-20 part, Radix Salviae Miltiorrhizae 15-20 part, Myrrha 15-20 part, Radix Astragali 15-20 part, Radix Bupleuri 15-20 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101077708A CN100444850C (en) | 2003-12-23 | 2003-12-23 | Chinese traditional medicine for treating skin diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101077708A CN100444850C (en) | 2003-12-23 | 2003-12-23 | Chinese traditional medicine for treating skin diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1631381A CN1631381A (en) | 2005-06-29 |
| CN100444850C true CN100444850C (en) | 2008-12-24 |
Family
ID=34843024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2003101077708A Expired - Fee Related CN100444850C (en) | 2003-12-23 | 2003-12-23 | Chinese traditional medicine for treating skin diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100444850C (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102166322A (en) * | 2011-04-01 | 2011-08-31 | 赵伏成 | Fumigating medicine for treating ichthyosis |
| CN102657812A (en) * | 2012-01-09 | 2012-09-12 | 付吉星 | Traditional Chinese medicine composition for treating eczema |
| CN102552970B (en) * | 2012-01-12 | 2013-12-04 | 吕慧 | Wet plaster of eczema dermatitis |
| CN104288346A (en) * | 2013-08-20 | 2015-01-21 | 张霞 | Traditional Chinese medicine ointment for treating dermatosis, and preparation method thereof |
| CN103784539B (en) * | 2014-01-15 | 2016-05-04 | 中国人民解放军第二军医大学 | One is treated psoriatic Chinese medicine composition and preparation and application |
| CN104606314A (en) * | 2015-03-04 | 2015-05-13 | 马宁 | Traditional Chinese medicine for treating oral lichen planus and preparation method thereof |
| CN104873765A (en) * | 2015-05-28 | 2015-09-02 | 王玉波 | Traditional Chinese medicine liniment for treating head-wind white scaling |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1333028A (en) * | 2000-07-12 | 2002-01-30 | 赵树人 | External liniment for treating rheumatic arthritis |
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
-
2003
- 2003-12-23 CN CNB2003101077708A patent/CN100444850C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1333028A (en) * | 2000-07-12 | 2002-01-30 | 赵树人 | External liniment for treating rheumatic arthritis |
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1631381A (en) | 2005-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7147876B2 (en) | Compositions for removal of toxins | |
| CN104586669A (en) | Fat-reducing externally-applied cream | |
| CN103432559B (en) | Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof | |
| CN100444850C (en) | Chinese traditional medicine for treating skin diseases | |
| CN105963467A (en) | Traditional Chinese medicine composition, application thereof and preparation | |
| CN105748374A (en) | Traditional Chinese medicine toner with effect of tendering and caring skin | |
| CN101926857A (en) | Traditional Chinese medicinal liniment for treating vitiligo | |
| CN104758529A (en) | Traditional Chinese medicine composition for treating common cold due to wind-cold | |
| CN110538308B (en) | Traditional Chinese medicine composition for hair growth and preparation method thereof | |
| CN105477381A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN105381289A (en) | Pharmaceutical composition for treating abnormal menstruation | |
| CN101856476A (en) | Chinese medicament for treating stomachache | |
| CN104758652A (en) | Traditional Chinese medicine composition for treating dizziness | |
| CN103735879A (en) | Traditional Chinese medicine decoction for treating carotid artery plaque | |
| CN103638287A (en) | Chinese medicine composition for treating schizophrenia | |
| CN100350950C (en) | Wuzishan Chinese medicines for cancer pains | |
| CN102988776A (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN102423367B (en) | Beautifying and blood-activating medicament | |
| CN101843825B (en) | Chinese medicament for treating climacteric syndromes | |
| CN104997681A (en) | Acne removing skin-cleansing lotion | |
| CN100490866C (en) | Ready prepared Chinese medicine for treating deep source nasal congestion | |
| CN104857229A (en) | Traditional Chinese medicine composition for curing body odor or kakidrosis and preparation method thereof | |
| Chen | Herbology in Three Traditional Medicines for Acne | |
| CN105311335A (en) | Traditional Chinese medicine composition for assisting tumor chemoradiotherapy | |
| CN104940399B (en) | A kind of drug for treating skin pigment depigmentation and leucoderma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081224 Termination date: 20100125 |